期刊文献+

中药单体川芎嗪在疾病治疗中的应用与机制研究进展 被引量:23

Research progress on application and mechanism of traditional Chinese medicine tetramethylpyrazine in disease treatment
下载PDF
导出
摘要 川芎嗪又称四甲基吡嗪,是提取自伞形科藁本属植物川芎根茎的一种中药单体成分,属于酰胺类生物碱。川芎嗪除了具有传统的活血祛瘀、抑制血小板聚集、扩张血管、改善血液循环、缓解疼痛等作用外,随着研究的不断深入,发现川芎嗪还具有心脑血管疾病预防与治疗、多器官如心脏、脑组织和肾脏等的缺血再灌注损伤修复、血管内皮保护、肿瘤抑制、哮喘病人气道重塑、钙超载抑制和免疫调节等作用。现从川芎嗪在心血管疾病、脑疾病、肾损伤、肿瘤等疾病中的应用,对近几年川芎嗪最新研究进展进行综述,以期为川芎嗪的临床应用提供参考。 Ligustrazine also known as tetramethylpyrazine(TMPZ),is a kind of monomer component of traditional Chinese medicine extracted from the rhizome of Ligusticum chuanxiong hort,which belongs to amide alkaloids.Ligustrazine has the classic functions of promoting blood circulation and removing blood stasis,inhibiting platelet aggregation,dilating blood vessels,improving blood circulation,and relieving pain.In addition,with the deepening of research,it was found that ligustrazine also has the functions of prevention and treatment of cardiovascular and cerebrovascular diseases,repair of ischemia-reperfusion injury of multiple organs such as heart,brain tissue and kidney,vascular endothelial protection,tumor inhibition,airway remodeling,calcium overload inhibition and immune regulation in asthma patients.This article will review the latest research progress of ligustrazine in recent years from the application of ligustrazine in cardiovascular disease,brain disease,kidney injury,tumor and other diseases,in order to provide reference for the clinical application of ligustrazine.
作者 周鑫 孙晓莹 贾礼伊 郭蒙 靳洁 王引弟 黄领 李奕衡 何钟竞 曹慧玲 ZHOU Xin;SUN Xiaoying;JIA Liyi;GUO Meng;JIN Jie;WANG Yindi;HUANG Ling;LI Yiheng;HE Zhongjing;CAO Huiling(Shaanxi Key Laboratory of Ischemic Cardiovascular Diseases,Institute of Basic&Translational Medicine,Xi'an Medical University,Xi’an 710021,China)
出处 《陕西中医》 CAS 2022年第4期541-544,共4页 Shaanxi Journal of Traditional Chinese Medicine
基金 陕西省科技厅自然科学青年基金资助项目(2020JQ-885) 陕西省教育厅重点实验室项目(20JS138) 西安医学院博士基金资助项目(2020DOC28)。
关键词 川芎嗪 心血管疾病 脑疾病 肾损伤 肿瘤 Ligustrazine Cardiovascular disease Brain disease Kidney injury Tumor
  • 相关文献

参考文献18

二级参考文献225

共引文献186

同被引文献362

引证文献23

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部